Skip to main content
placeholder image

NAP-CAPABIL: Pilot study of NAB-paclitaxel in combination with capecitabine as second line treatment of advanced biliary cancer.

Journal Article


Abstract


UOW Authors


Publication Date


  • 2018

Citation


  • Aghmesheh, M., Brungs, D., Leighton, C., & Sjoquist, K. M. (2018). NAP-CAPABIL: Pilot study of NAB-paclitaxel in combination with capecitabine as second line treatment of advanced biliary cancer.. Journal of Clinical Oncology, 36(15_suppl), e16156. doi:10.1200/jco.2018.36.15_suppl.e16156

Web Of Science Accession Number


Start Page


  • e16156

End Page


  • e16156

Volume


  • 36

Issue


  • 15_suppl

Abstract


UOW Authors


Publication Date


  • 2018

Citation


  • Aghmesheh, M., Brungs, D., Leighton, C., & Sjoquist, K. M. (2018). NAP-CAPABIL: Pilot study of NAB-paclitaxel in combination with capecitabine as second line treatment of advanced biliary cancer.. Journal of Clinical Oncology, 36(15_suppl), e16156. doi:10.1200/jco.2018.36.15_suppl.e16156

Web Of Science Accession Number


Start Page


  • e16156

End Page


  • e16156

Volume


  • 36

Issue


  • 15_suppl